Heron Therapeutics
HRTX
#8263
Rank
C$0.22 B
Marketcap
$1.48
Share price
-5.36%
Change (1 day)
-17.37%
Change (1 year)

EPS for Heron Therapeutics (HRTX)

EPS in 2023 (TTM): -$1.58

According to Heron Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.64. In 2022 the company made an earnings per share (EPS) of -$2.42 an increase over its 2021 EPS that were of -$3.15.

EPS history for Heron Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.58-34.76%
2022-$2.42-23.11%
2021-$3.15-10%
2020-$3.50-0%
2019-$3.501.21%
2018-$3.46-32.7%
2017-$5.13-19.34%
2016-$6.3754.76%
2015-$4.111.73%
2014-$4.04-16.23%
2013-$4.8391.67%
2012-$2.52-31.45%
2011-$3.67-27.06%
2010-$5.04-43.75%
2009-$8.95-57.33%
2008-$20.99-82.92%
2007-$122.8420.61%
2006-$101.86175.76%
2005-$36.94-21.43%
2004-$47.01100%
2003-$23.51-38.24%
2002-$38.06161.54%
2001-$14.55-106.46%
2000$225.112051.55%
1999$10.46839.73%
1998$1.11-105.48%
1997-$20.33-88.16%
1996-$171.73

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$1.82-211.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$0.20-111.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.28 39.32%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.20-234.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.31 41.03%๐Ÿ‡บ๐Ÿ‡ธ USA